New COVID-19 vaccines: here's how the promising Novavax and Johnson & Johnson jabs work

By Sarah Pitt, Principal Lecturer, Microbiology and Biomedical Science Practice, Fellow of the Institute of Biomedical Science, University of Brighton

Thanks to the efforts of scientists, healthcare workers and trial participants around the world, a number of COVID-19 vaccines have now been authorised for general use. But while millions have been given a jab, billions still need to be vaccinated. We need to produce as many doses as we can.

So, it’s good news that two additional vaccines are on the horizon. Vaccine developers Novavax and Johnson & Johnson recently released data from the phase 3 clinical trials of their jabs,…

Read complete article

~	Will Solomon Islands’ new leader stay close to China?

~	Ukraine: Russian Forces Executed Surrendering Ukraine Soldiers

~	Kenya: Floods Threaten Marginalized People

~	Resounding Support for a ‘Killer Robots’ Treaty

~	Global: A Web of Surveillance – Unravelling a murky network of spyware exports to Indonesia

~	A clock in the rocks: what cosmic rays tell us about Earth’s changing surface and climate

~	Aggressive? Homophobic? Stoic? Here’s what thousands of Australian men told us about modern masculinity

~	Australia: Rights Vetting Crucial for Defence Cooperation

~	Do we really need to burp babies? Here’s what the research says

~	You’ve been ‘volun-told’ to coach junior sport – here’s how to best handle the parents involved